A Peek Into The Market Before The Trading Starts - MGM Resorts Intl (NYSE:MGM), Fresh Del Monte Produce (NYSE:FDP)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Pre-open moversUS stock futures are higher this morning, as investors are awaiting housing market index. Futures for the Dow Jones Industrial Average surged 21 points to 13,969.00 and S&P 500 index futures rose 1.30 points to 1,518.40. Nasdaq 100 futures climbed 2.50 points to 2,763.75.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 0.61%, London's FTSE 100 Index gained 0.29%, German DAX 30 Index rose 0.79% and French CAC 40 Index climbed 1.10%.Asian markets ended mixed, with Japan's Nikkei Stock Average falling 0.31%, China's Shanghai Composite dropping 1.60% and Australia's S&P/ASX 200 Index gaining 0.36%. Hong Kong's Hang Seng Index fell 1.02% and India's Sensex gained 0.69%.Broker Recommendation

Analysts at RBC Capital upgraded MGM Resorts International (NYSE: MGM) from “sector perform” to “outperform.” The target price for MGM Resorts has been raised from $13 to $16. MGM Resorts shares gained 0.16% to $12.90 in pre-market trading. Breaking news

Fresh Del Monte Produce (NYSE: FDP) reported a break-even profit for the fourth quarter. To read the full news, click here.
Today, Microsoft (NASDAQ: MSFT) announced that its highly popular email service, Outlook.com, is ready for primetime. To read the full news, click here.
Westlake Chemical (NYSE: WLK) reported a surge in its fourth-quarter profit. To read the full news, click here.
Regeneron Pharmaceuticals (NASDAQ: REGN) and Bayer HealthCare today announced that they have initiated a new Phase 3 trial to evaluate the efficacy and safety of EYLEA® (aflibercept) Injection in the treatment of Diabetic Macular Edema (DME) in Russia, China, and other Asian countries. To read the full news, click here.